Understanding Equine IgG Subclasses for Better Vaccines
Author Information
Author(s): Melanie J. Lewis, Bettina Wagner, Jenny M. Woof
Primary Institution: University of Dundee Medical School
Hypothesis
The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.
Conclusion
Equine vaccine strategies should aim to elicit antibody responses from the IgG1, IgG3, IgG4, and IgG7 subclasses for maximum efficacy.
Supporting Evidence
- IgG1, IgG3, IgG4, and IgG7 subclasses can elicit strong immune responses.
- IgG2 and IgG6 subclasses do not effectively interact with immune cells.
- IgG3 is the most potent activator of the complement system.
Takeaway
Horses have different types of antibodies called IgG subclasses, and some are better at fighting off germs than others. To make better vaccines for horses, we need to focus on the right types of these antibodies.
Methodology
Recombinant versions of the seven equine IgG subclasses were expressed in CHO cells and analyzed for their physical and biological properties.
Limitations
The study does not explore the interactions of equine IgG subclasses with horse complement in detail.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website